Hepatocellular Carcinoma (HCC) Trials in the UK

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Download CSV

Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 2852 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 17 Sep 2026, 08:23 UTC

2852

Studies in scope

industry-sponsored, all four open statuses

1378

Recruiting now

open to new participants

540

Lead sponsors

across recruiting studies

Top sites

London 1 Glasgow 1 Metropolitan Borough of Wirral 1 Manchester 1

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Site city

All 4 cities

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

NCT07291076Hepatocellular Carcinoma (HCC)

Bristol-Myers Squibb

Phase 1/2

198

London, Glasgow, Metropolitan Borough of Wirral

2026-03-16

Not yet open

International Study on Treatment of Liver (HCC) Patients With IRE

NCT07192731Hepatocellular Carcinoma (HCC), Liver Ablation, Liver Cancer, Adult

Angiodynamics, Inc.

Not applicable

Manchester

2026-02

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 September 2026. https://priyalifescience.com/clinical-trials-uk/condition/hepatocellular-carcinoma-hcc

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →

Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the UK Pharma Salary Guide, or see the Ireland, EU and USA registers.